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We report biodegradable electroactive polymer (EAP)-based materials and their application 
as drug delivery devices. Copolymers composed of oligoaniline-based electroactive blocks 
linked to either polyethylene glycol or polycaprolactone blocks via ester bonds were 
synthesized in three steps from commercially available starting materials and isolated without 
the need for column chromatography. The physicochemical and electrochemical properties of 
the polymers were characterized with a variety of techniques. The ability of the polymers to 
deliver the anti-inflammatory drug dexamethasone phosphate on the application of 
electrochemical stimuli was studied spectroscopically. Films of the polymers were shown to 
be degradable and cell adhesive in vitro. Such EAP-based materials have prospects for 
integration in implantable fully biodegradable/bioerodible EAP-based drug delivery devices 
that are capable of controlling the chronopharmacology of drugs for future clinical 
application. 
 
Introduction 
Systems capable of precisely controlling levels of drugs in specific tissues or the blood 
stream potentially allow maintenance of the drug above its minimum effective level and 
below the level at which its use results in unwanted side effects. Furthermore, as our 
understanding of chronobiology has deepened, we have become aware of its importance in a 
variety of conditions including Alzheimer's disease, cancer, cardiovascular diseases, diabetes, 
epilepsy, pain, Parkinson's disease and infectious diseases.1–3 Such conditions can be treated 
most effectively by drugs with chronopharmacologies synchronized with the chronobiology 
of the specific condition.2–6 Chronobiological processes that are governed on a genetic level 
by clock genes display rhythmic endogenous oscillations driven by the circadian clock (i.e. 
circadian rhythms). Perturbations of circadian rhythms are involved with a variety of 
conditions (including cancers, depression, diabetes, and sleep disorders), as discussed in 
detail in a selection of excellent reviews,1,7–11 and such conditions are attractive targets for 
chrono-specific treatments.12–14  
Stimuli-responsive drug delivery systems are particularly attractive for the treatment of such 
conditions because of their potential for the controlled delivery of precise quantities of drugs 
at specific locations and times. Materials responding to stimuli such as enzymes, light, pH, 
temperature, ultrasound and electric/magnetic fields have been developed for use as drug 
delivery devices.2,3,6,15–30 An exciting new research area is the development of electroactive 
materials capable of controlling either cell behavior or the delivery of drugs.31–35 Here we 
report the first application of biodegradable EAP-based materials for electrochemically-
triggered drug delivery. 
EAPs are of scientific interest because of their potential for application in the electronics36–38 
and biomedical31–33,35,39–59 industries. Although there are a number of different EAPs,36–
39,56,60,61 those most commonly investigated for biomedical applications are derivatives of 
polyaniline, polypyrrole, polythiophene and poly(3,4-ethylenedioxythiophene).31–33,50,56,57,62 
The highly conjugated backbone of EAPs synthesized via conventional means (e.g., 
electrochemical polymerization of the constituent monomers at the surface of an electrode, or 
the solution/solid state polymerization of the monomers in the presence of a catalyst) is 
responsible for their high conductivity, and the lack of enzymatically cleavable moieties (e.g., 
amides or esters) renders them non-biodegradable. Clearly, non-biodegradable EAPs are best 
suited for devices that will be implanted for long periods such as electrodes for the recording 
or stimulation of neuronal activity,51,52 whereas, biodegradable EAPs are ideal for devices 
implanted for comparatively short durations such as drug delivery devices or tissue 
scaffolds.33,35,63–67 The Miller group reported the first conceptually biodegradable EAPs in 
1995.68 The multiblock copolymers were composed of electroactive oligothiophenes and non-
electroactive aliphatic spacers connected via ester bonds; however, iodine (a toxic oxidizing 
agent) was necessary to render them electroactive.68 Analogous structures described in the 
literature incorporated electroactive oligomers that were insoluble or aggregated in water.69 
This approach is not ideal for clinical applications as the insoluble/aggregated oligomers are 
likely to remain in the body after degradation of the bulk material. Rivers and co-workers 
were the first to report the preparation of fully biodegradable electroactive polyesters 
incorporating a water soluble electroactive oligomer (pyrrole–thiophene–pyrrole) displaying 
carboxylic acids at their termini,70 however, similar to earlier work, these polymers were only 
electroactive after oxidation with iodine. Guimard and co-workers subsequently described 
analogous systems in which the length of the electroactive oligomer was increased from 3 to 
4 heterocycles that could be doped with biocompatible anions (either chloride, Cl−, or 
perchlorate, ClO4−) and the resulting polymers were suitable for the attachment and 
proliferation of Schwann cells in vitro.71 The groups of Albertsson and Wei have reported a 
variety of biodegradable electrically EAPs through various combinations of short water 
soluble oligomers of aniline and biodegradable polymers of natural or synthetic origins.35,72–84 
Electrical stimulation of cells attached to the surfaces of camphorsulfonic acid-doped (CSA, 
Fig. 1) materials was demonstrated to enhance neurite extension from rat neuronal 
pheochromocytoma (PC12) cells,84 and increase levels of early markers of osteogenic 
differentiation of preosteoblastic MC3T3-E1 cells.85 Researchers have begun to address the 
cytotoxic degradation products of these polymers seen in vitro,86–88via the synthesis of 
oligoaniline analogues with reduced toxicities.86,87 The interested reader is directed towards 
the following recent reviews for a more thorough discussion of the potential of such materials 
for biomedical applications.32,33,35,50,51,55,56 
 
 
 Fig. 1 Camphorsulfonic acid (CSA) and dexamethasone phosphate (DMP).  
The Miller group was also the first to report the application of EAPs for drug delivery, 
demonstrating the ability to trigger the release of glutamate anions from polypyrrole films 
upon reduction of the polypyrrole.89 Since this exciting report, a variety of other biologically 
relevant anionic, cationic and neutral drugs with either low/high molecular weights have been 
shown to be deliverable using EAP-based materials (e.g., adenosine triphosphate,90 
dexamethasone phosphate (DMP, Fig. 1),91–93 DNA,94 dopamine,95,96 nerve growth 
factor,97N-methylphenothiazine98), as described in more detail in excellent reviews.55,58 It is 
noteworthy that all of the previously described systems use non-biodegradable EAPs as the 
stimulus-responsive matrix from which to deliver the drug. Here we report the first 
biodegradable EAP-based drug delivery devices, employing solution-processable EAPs that 
facilitate the preparation of materials with high drug loadings (16 to 31 wt%). 
Results and discussion 
Our prototypical biodegradable electroactive polyesters are multiblock copolymers composed 
of electrochemically responsive blocks of oligoaniline terminated with carboxylic acid 
moieties to ensure their water solubility, linked to alcohol-terminated blocks of either FDA-
approved polyethylene glycol (PEG) or polycaprolactone (PCL) via ester bonds. The 
molecular weight of each of the individual blocks is below 3 kDa, well below the renal 
filtration threshold of 70 kDa.99–101  
The carboxylic acid-terminated aniline pentamers (AP) were obtained in analytically pure 
form using minor modifications to the methodology described in the literature (Scheme 
S1†).102 Polyesters 1–4 were synthesized by adaptation of the literature.81 In short, the 
carboxylic acids displayed at the termini of the electroactive AP blocks were activated with 
dicyclohexylcarbodiimide (DCC) in the presence of a catalytic amount of 4-
dimethylaminopyridine (DMAP) and a stoichiometric quantity of alcohol-terminated PEGs 
(Scheme 1) or PCLs (Scheme 2), incorporating PEG-400, PEG-2000, PCL-530 or PCL-2000 
to prepare polyesters 1, 2, 3 or 4 respectively. The syntheses and purifications of the 
polyesters are simple and scalable, requiring only three steps from commercially available 
starting materials and no column chromatography. The success of the condensation 
polymerization was confirmed by the presence of the characteristic peaks for esters in the IR 
spectra (at ca. 1732 cm−1) and 13C NMR spectra (at ca. 174 ppm), and thermogravimetric 
analysis (TGA) confirmed that the diacid and diol blocks were present in a 1 : 1 ratio (Fig. S1 
and Table S1†). However, poor solubility (Table S2†) meant that determination of the 
molecular weight distributions of polyesters 1–4via standard techniques such as GPC/SEC, 
light scattering or MALDI-TOF mass spectrometry was not possible. 
 
 
 Scheme 1 Synthesis of electroactive polyesters 1 and 2via the Steglich esterification. (a) DCC, DMAP, NMP, 72 h, r.t.  
 
 
 Scheme 2 Synthesis of electroactive polyesters 3 and 4via the Steglich esterification. (a) DCC, DMAP, NMP, 72 h, r.t.  
We prepared CSA-doped films of the polyesters to compare their physicochemical properties 
with analogous oligoaniline-based materials reported in the literature. Black films of ca. 20 
μm thickness (as determined by profilometry) were prepared by casting solutions of the 
polymers and CSA in hexafluoroisopropanol (HFIP). Vacuum dried films of polyesters 1, 3 
and 4 were glossy, whereas those of polyester 2 were matte with spherulites owing to the 
crystallization of the PEG blocks. The wide angle XRD patterns for the films composed of 
polyesters 1, 3 and 4 are very broad, characteristic of polymers that are amorphous in the 
solid state (Fig. S2†). The wide angle XRD patterns for the films composed of polyester 2 
contain peaks at 2θ = 19.1° and 23.3°, corresponding to d-spacings of 4.6 Å and 3.8 Å 
respectively, which are characteristic of crystalline PEG chains (Fig. S2† and Table 1).103 In 
agreement with the literature, doping with bulky CSA anions reduced the crystallinity (Xc) of 
films of polyester 2 (Table 1).104 CSA doping also diminished the thermal stability of the 
films, as revealed by TGA (Fig. S1†) and reductions in glass transition temperatures (Tg) of 
polyesters 1, 3 and 4, and the melting and crystallization temperatures (Tm and Tc 
respectively) of polyester 2 as measured by differential scanning calorimetry (DSC) (Fig. S3† 
and Table 1). IR spectra of the CSA-doped films (Fig. S4†) show peaks characteristic of 
electroactive AP blocks, either the PEG or PCL blocks respectively, and the esters 
interspersed between them. UV-visible spectra of thin films of the polymers cast on quartz 
slides (Fig. 2) show peaks at ca. 330 nm corresponding to the benzenoid π–π* transition in 
the AP blocks and are evident for all samples; the peaks at ca. 442 nm evident in the CSA-
doped films correspond to the polaron band; the broad absorption after ca. 866 nm confirms 
the presence of emeraldine salts of the AP blocks, and the broad absorption after ca. 1000 nm 
corresponds to the “free carrier tail” reported for analogous electroactive block 
copolymers.88,105 
Table 1 Surface and physicochemical properties of the polyester films  
 
 
R a 
(μm) R q (μm) 
R ZDIN 
(μm) X c  
T g 
(°C) 
T c 
(°C) 
T m 
(°C) 
Conductivity, σ 
(S cm−1) 
a As determined by XRD. b Not applicable. c Amorphous. d Not determined (below 0 
°C).  
Glass substrate 0.730 ± 
0.153 
0.905 ± 
0.182 
3.8303 ± 
2.04 
N/Ab N/Ab N/Ab N/Ab N/Ab 
Polyester 1 
undoped 
1.474 ± 
1.449 
4.312 ± 
3.684 
12.099 ± 
11.493 
0.0 72.4 N/Ab,c N/Ab,c 1.81 × 10−9 ± 6% 
Polyester 1 
doped with 
CSA 
0.461 ± 
0.421 
0.530 ± 
0.485 
1.109 ± 
0.710 
0.0 51.5 N/Ab,c N/Ab,c 3.38 × 10−8 ± 1% 
Polyester 2 
undoped 
11.49 ± 
1.26 
12.926 ± 
1.089 
44.196 ± 
3.155 
49.8 N/Dd 22.7 53.1 4.01 × 10−10 ± 
14% 
Polyester 2 
doped with 
CSA 
0.449 ± 
0.061 
0.572 ± 
0.099 
2.717 ± 
0.523 
13.4 N/Dd 28.4 53.4 8.34 × 10−8 ± 2% 
Polyester 3 
undoped 
0.303 ± 
0.051 
0.479 ± 
0.182 
1.669 ± 
0.535 
0.0 50.5 N/Ab,c N/Ab,c 1.80 × 10−9 ± 6% 
Polyester 3 
doped with 
CSA 
0.668 ± 
0.082 
1.111 ± 
0.178 
2.649 ± 
0.874 
0.0 37.6 N/Ab,c N/Ab,c 6.14 × 10−9 ± 3% 
Polyester 4 
undoped 
0.273 ± 
0.191 
0.315 ± 
0.218 
0.747 ± 
0.542 
0.0 41.8 N/Ab,c N/Ab,c 6.04 × 10−10 ± 
14% 
Polyester 4 
doped with 
CSA 
0.598 ± 
0.097 
0.727 ± 
0.147 
1.674 ± 
0.173 
0.0 39.7 N/Ab,c N/Ab,c 2.20 × 10−8 ± 2% 
 
  
 
Fig. 2 UV-visible spectra of thin polyester films on quartz slides. (A) Polyester 1 undoped, 
black line; polyester 1 doped with CSA, dashed black line; polyester 2 undoped, grey line; 
polyester 2 doped with CSA, dashed grey line; (B) polyester 3 undoped, black line; 
polyester 3 doped with CSA, dashed black line; polyester 4 undoped, grey line; polyester 4 
doped with CSA, dashed grey line. 
 
Cyclic voltammograms of HCl-doped solutions of polyesters 1–4 (Fig. S5†), presented redox 
processes at ca. 0.26 V (leucoemeraldine to emeraldine 1 transition), ca. 0.42 V (emeraldine 1 
to emeraldine 2 transition), and ca. 0.6 V (emeraldine 2 to pernigraniline transition), in 
agreement with the literature76,78 and depicted in Scheme S2.† Potentials are reported vs. a 
Ag/AgCl reference electrode calibrated with ferrocenemethanol prior to every experiment 
(Fig. S6†). 
The conductance of films of polyesters 1–4 were measured in accordance with protocol IPC-
TM-650, number 2.5.17.2 of the Institute for Interconnecting and Packaging Electronic 
Circuits. Undoped polyesters had low conductivities on the order of 10−10 or 10−9 S cm−1. 
Doping with CSA moderately higher conductivities, typically by an order of magnitude to 
10−9 or 10−8 S cm−1 (Table 1), that are somewhat lower than analogous oligoaniline-based 
structures.35,72,75,77,78,88 Polyesters incorporating the low molecular weight diols (polyesters 1 
and 3) had lower conductivities than the polyesters incorporating higher molecular weight 
diols (polyesters 2 and 4), probably because the higher molecular weight diols in polyesters 2 
and 4 phase separate into PEG- or PCL-rich phases and AP-rich phases. Other researchers 
have concentrated on developing biodegradable/bioerodible tissue scaffolds with 
conductivities mimicking bodily tissues (typically in the range of 10−4 S cm−1 or higher)106–108 
to deliver biomimetic electric currents (in the μA regime) to electrically stimulate cells.109–114 
However, for our envisioned application as implantable devices for electrochemically-
triggered drug delivery, conductivities lower than mammalian tissues are preferable, and 
allow triggered drug release at specific points in time upon the application of an electrical 
potential directly to the EAP, thereby facilitating synchronized control of the 
chronopharmacology of the drug in line with the chronobiology of the specific condition. 
We studied the capability of the oligoaniline-based polymers to deliver an anti-inflammatory 
drug dexamethasone phosphate (DMP, MW 490 Da) into phosphate buffered saline (PBS). 
Dexamethasone was chosen because it is used in the clinic (often in multiple doses) and it is 
simple to monitor its release via UV spectroscopy. Films composed of polyesters 1–4 and 
DMP (of ca. 3 to 4 mg) were prepared on bioinert conductive and non-conductive substrates 
(glassy carbon electrodes and glass, respectively). DMP loadings were at a mole ratio of 1 : 1 
DMP : AP (ca. 31 wt% for polyesters 1 and 3, and ca. 16 wt% for polyesters 2 and 4). The 
experimental setups are depicted in Fig. S7.† The setup depicted in Fig. S7A† (using films 
deposited on glassy carbon substrates) is akin to that used for electrodes implanted for 
stimulation of the central nervous system in which the tissue surrounding the implant is used 
as a counter electrode.51,52,59,115,116 The setup depicted in Fig. S7B† (using films deposited on 
glass substrates) is a simple closed circuit similar to those proposed to power some 
electroactive tissue scaffolds.32–34 
Electrochemically-triggered release (i.e., de-doping) of DMP from the films was studied by 
voltammetry for films deposited on glassy carbon substrates. Evidence of the electrochemical 
de-doping process was clear from the sequentially diminished current densities during 
repetitive potential cycling of the films at v = 50 mV s−1 (Fig. S8–S11† for polyesters 1–4), 
concomitant with increasing absorbance of the PBS at the characteristic absorbance 
maximum of DMP (242 nm) as observed via UV spectroscopy. Pulsatile release from films 
deposited on glassy carbon substrates was studied by chronoamperometry using 1 minute of 
electrical stimulation followed by 14 minutes of rest (Fig. 3A) after which the quantity of 
DMP in solution was quantified by UV spectroscopy. The medium was unchanged between 
cycles. The data are reported as cumulative release as a percentage of the total mass of drug 
in the film and compared to DMP release from unstimulated films. Voltammetry scans and 
chronoamperometry pulses were always initiated at the open circuit potential of the system. 
Potential cycling was carried out between 0.7 V and −0.5 V, first sweeping in the positive 
direction of the potential scale at 50 mV s−1. Passive release of DMP from unstimulated films 
was low over the course of the experiment (1.5 hours), ca. 8% for polyester 1, ca. 3% for 
polyester 2 and ca. 2% for polyesters 3 and 4 (Fig. 3B). Over the period of 24 days this 
increased to ca. 83% for polyesters 1 and 2, ca. 48% for polyester 3 and ca. 35% for polyester 
4 (Fig. S12†). Passive release from the PEG-based polyester films (i.e. polyesters 1 and 2) 
was higher than from the PCL-based polyester films (i.e. polyesters 3 and 4) due to the more 
hydrophilic nature of the PEG backbones. In contrast, electrochemically-triggered release of 
the drugs by potential cycling (Fig. 3B) resulted in the release of ca. 20–65% of the drug 
during the initial cycle. Subsequent cycles were observed to release 5–10% per cycle for the 
first six cycles, after which the majority of the drug had been released from all of the films. 
 
  
Fig. 3 Electrochemically-triggered drug delivery via potential cycling. (A) Electrical 
stimulation paradigm: 6 cycles of 1 minute on, 14 minutes off. (B) Release of DMP from 
films of 1–4 in PBS as determined by UV spectroscopy. Electrochemically-triggered DMP 
release (solid bars) or passive DMP release without electrical stimulation (checked bars). 
Polyester 1, red. Polyester 2, blue. Polyester 3, green. Polyester 4, purple. 
 
We also studied the electrochemically-triggered release of DMP from films deposited on 
glass substrates. A potential step of +0.6 V was applied to each film for 30 seconds, followed 
by 29.5 minutes of rest (Fig. 4A) after which the quantity of DMP in solution was quantified 
by UV spectroscopy. The first stimulation released 5–25% of the drug from the films (Fig. 
4B), the first and second stimulation released 25–50%, and the third stimulation released 
between 50 to 90% of the drugs from the films, all of which are clearly distinguishable from 
the passive release profiles (Fig. 4B and S12†). 
 
  
Fig. 4 Electrochemically-triggered drug delivery via a potential step. (A) Electrical 
stimulation paradigm: 3 cycles of 0.5 minutes on, 29.5 minutes off. (B) Release of DMP 
from films of 1–4 in PBS as determined by UV spectroscopy. DMP release with electrical 
stimulation (solid bars) or without electrical stimulation (checked bars). Polyester 1, red. 
Polyester 2, blue. Polyester 3, green. Polyester 4, purple. 
 
Although it is impossible to accurately reproduce the conditions that materials encounter 
when implanted in vivo in the laboratory (particularly the complex tissue-specific distribution 
of enzymes, or patient-specific immune response), laboratory-based in vitro degradation 
studies are useful to confirm the potential for materials to degrade upon exposure to enzymes 
found in vivo. To demonstrate the susceptibility of the polymers to enzymatic/hydrolytic 
degradation in vitro we incubated films of polyesters 1–4 in PBS in the absence or presence 
of a high concentration of cholesterol esterase (4 units per mL) which is an enzyme known to 
hydrolyze ester bonds in polyesters.71,117,118 We observed the mass of each film to decrease 
very slowly over a period of 10 days, and the presence of the esterase moderately increased 
the rate at which this occurs (Fig. S13†). We conclude that the films would degrade slowly if 
administered in vivo (over the period of several months) in line with other PEG- and PCL-
based materials.119,120 
As noted above, non-toxic FDA-approved PEG and PCL derivatives were chosen as the non-
electroactive units for inclusion in the biodegradable polyesters, and degradation of the 
polyesters would lead to the release of low molecular weight polyethylene glycols or 
caprolactone derivatives that are easily cleared via the renal system. The toxicity of the 
electroactive oligoaniline incorporated in the polymers was first reported by Wei and co-
workers using the rat glial tumor C6 cell line, in a study that showed the aniline pentamer 
displays little/no cytotoxicity below 20 mg mL−1, 90% cell viability at 40 mg mL−1, and 
approximately 50% cell viability at 100 mg mL−1.121 Subsequent studies by Wei and co-
workers showed the aniline pentamer to be more toxic towards adenocarcinomic human 
alveolar basal epithelial A549 cells, with little/no cytotoxicity below 20 μg mL−1, 90% cell 
viability at 40 μg mL−1, and approximately 50% cell viability at 100 μg mL−1; furthermore, 
shorter oligoanilines were less cytotoxic.86,87 
Pertinently, a study of PCL-based polyesters incorporating the aniline pentamer from Guo 
and Albertsson investigating the toxicity of the water soluble extracts collected after 
incubating the polyesters in medium typically showed human keratinocyte HaCaT cells to be 
ca. 90% viable using a variety of polymer compositions and architectures.72 We adapted this 
methodology to investigate the toxicity of the water soluble extracts collected after incubating 
polyesters 1–4 in medium for 5 days, using pristine medium as a positive control experiment 
and pristine medium containing 15 vol% of ethanol as a negative control experiment. After 
exposure of human dermal fibroblast (HDF) cells to 15 vol% of ethanol we found them to be 
ca. 11% viable (i.e. cell viability was adversely affected), as depicted in Fig. 5. By 
comparison, HDFs incubated in either the pristine media or the media containing any water 
soluble extracts from polyesters 1–4 began to proliferate (i.e. cell viability was not adversely 
affected). 
 
 
 
Fig. 5 Assessment of the cytocompatibility of the water soluble extracts from polyesters 1–
4 incubated in media for 5 days towards human dermal fibroblasts as determined by 
AlamarBlue® assay. Day (0) Black bars. Day (2) Grey bars. Day (4) White bars. 
 
Analogous CSA-doped materials have been shown to support the adhesion of a variety of 
cells including C6 cells,122 keratinocytes,72 MC3T3-E1 cells,85 osteoblasts,122 PC12 cells121 
and Schwann cells.122–124 We found that films of polyesters 1 and 3 were prone to fracture as 
a consequence of exposure to dynamic shear forces encountered during multiple medium 
changes at 37 °C. Films of polyesters 2 and 4 were more robust and we observed that both 
HDFs and human mesenchymal stem cells (HMSCs) adhered to the surface of the films with 
morphologies analogous to those on commercially available conductive indium tin oxide 
(ITO) slides (Fig. S14†). Longer term HDF proliferation studies were complicated by poor 
adhesion of the films of polyesters 2 and 4 to either ITO slides or tissue-culture treated 
Corning® Costar® tissue culture plates, and their mechanical stability, yet HDFs were 
observed to adhere and remain viable over 4 days (Fig. S15†). After 8 days in culture HDFs 
had proliferated on their surfaces (Fig. 6) and a LIVE/DEAD® Viability/Cytotoxicity Kit for 
mammalian cells demonstrated that they were highly viable (Fig. 7). 
 
 
 Fig. 6 Adhesion of human dermal fibroblasts on various surfaces after 8 days in culture. 
(A) Tissue-culture treated Corning® Costar® tissue culture plates. (B) CSA-doped 
polyester 2. (C) CSA-doped polyester 4. Live cells were stained green by calcein and dead 
cells were stained red by ethidium using a LIVE/DEAD® Viability/Cytotoxicity Kit. Scale 
bars represent 100 μm. 
 
 
 
 
Fig. 7 Assessment of the cell viability of human dermal fibroblasts on various surfaces 
after 8 days in culture as determined using a LIVE/DEAD® Viability/Cytotoxicity Kit. 
(Black bar) Tissue-culture treated Corning® Costar® tissue culture plates. (Grey bar) 
CSA-doped polyester 2. (White bar) CSA-doped polyester 4. 
 
Together, these results suggest that such copolymers represent valuable lead structures for the 
development of clinically relevant electroactive biomaterials, with potential for in vivo 
implantation for a variety of applications (e.g., drug eluting coatings on completely 
biodegradable implants). 
Conclusions 
Electrically triggered drug release from polyesters 1–4 provides a novel platform for drug 
delivery. The synthesis and purification of the polymers is simple and scalable, requiring only 
3 steps from commercially available starting materials. The polymers are solution 
processable, thus facilitating the preparation of materials with a high drug loading of 16 or 31 
wt%. Although we used the anti-inflammatory DMP as a clinically applied model drug 
(primarily because it is straightforward to quantify its release using UV spectroscopy), it is 
noteworthy that a wide variety of other biologically-active molecules (such as those for the 
treatment of pain) could be delivered using the stimulation paradigms described here. 
Furthermore, it would be possible to modulate the release profiles of these molecules via 
simple modifications of the electrical input, allowing the release profile to be tailored to treat 
the condition in the most therapeutically effective way. Both the experimental paradigms 
described have potential to be used for the manufacture of completely biodegradable drug 
delivery systems.125 The potential cycling-induced release paradigm could be powered 
wirelessly.117 The potential step-induced release paradigm could be powered using a 
sacrificial metal such as magnesium although this may result in the build-up of hydrogen in 
vivo (which can be diminished using zinc alloys).54,126–128 A safer option to power the 
potential step-induced release paradigm would be the use of a biodegradable battery, which is 
capable of providing potentials of up to 0.6 V as used in this study.129 The other requisite 
circuit components such as sensors, switches and wires could be manufactured from 
biodegradable/bioerodible EAP-based materials,130–133 all of which would be embedded 
within a non-conductive biodegradable polymer capsule. Moreover, the biodegradable and 
cytocompatible nature of the polyesters suggests that analogous materials may be of use as 
tissue scaffolds. Consequently, we foresee great potential for the development of 
biodegradable EAP-based drug delivery devices integrated into tissue scaffolds,33,35 and, 
moreover, the exciting prospect of systems capable of controlling the chronopharmacology of 
drugs in a clinically relevant fashion.10,30,134–136  
Experimental 
Materials 
Unless otherwise stated, all chemicals for synthesis and physicochemical analysis were of 
ACS grade, purchased from Sigma-Aldrich and used as received without further purification. 
Reagents for cell culture were purchased from Invitrogen (Carlsbad, CA) unless otherwise 
noted. Human dermal fibroblasts (HDFs) and human mesenchymal stem cells (HMSCs) were 
purchased from Lonza (Gaithersburg, MD). Tissue-culture treated Corning® Costar® tissue 
culture plates were purchased from Sigma Aldrich and pristine indium tin oxide (ITO) slides 
were purchased from Ted Pella, Inc. (Reading, CA).  
Synthetic/analytical methods 
1H and 13C NMR spectra were recorded on a Varian Mercury 400 MHz NMR spectrometer, 
using residual solvent 1H peaks as internal references for the 1H NMR spectra and the solvent 
13C peaks as references for the 13C NMR spectra. The following notation is used for the 1H 
NMR spectral splitting patterns: singlet (s), doublet (d), multiplet (m), broad (br). Mass 
spectra were recorded on an Agilent 6530 QTOF mass spectrometer in electrospray 
ionization mode. Infrared spectroscopy was carried out on a Thermo Scientific Nicolet 380 
FT-IR Spectrometer (Thermo Fisher Scientific Inc., USA). Spectra were recorded in ATR 
mode at 21 °C, with a 1 cm−1 resolution and 16 scans (corrected for background and 
atmosphere using OMNIC software provided with the spectrometer).  
Synthesis of carboxylic acid-terminated aniline pentamers (APs). The synthesis of the 
carboxylic acid-terminated aniline pentamers was adapted from the method of Wei and co-
workers.102N-phenyl-1,4-phenylenediamine (9.2 g, 50 mmol) and succinic anhydride (5.0 g, 
50 mmol) were dissolved in dichloromethane (300 mL) and stirred overnight at room 
temperature. The product was isolated by filtration, washed with diethyl ether until the 
diethyl ether was clear and colorless, and dried under vacuum for 24 hours, yielding 12.0 g 
(42 mmol, 84% yield) of blue-grey solid (a succinic acid-capped aniline dimer). This blue-
grey solid (2.9 g, 10 mmol) and p-phenylenediamine (0.54 g, 5 mmol) were dissolved in 
dimethylformamide (DMF, 15 mL) and the solution cooled to 0 °C on ice. A cooled solution 
of DMF (30 mL), water (25 mL) and concentrated hydrochloric acid (5 mL) was added. A 
solution of ammonium persulfate (2.28 g, 10 mmol) in aqueous hydrochloric acid solution 
(50 mL, 1 M) was added slowly and the reaction mixture stirred quickly for 1 hour at 0 °C. 
After this time the reaction mixture was added to water (300 mL) resulting in the 
precipitation of a solid, which was isolated by filtration. The product was reduced by stirring 
a suspension of the product in aqueous ammonia (300 mL, 1 M) overnight, after which the 
pH was lowered to 2–3 by addition of aqueous hydrochloric acid (1 M), and the product 
isolated by filtration. The product was dried under vacuum at 45 °C for 48 hours. A solution 
of the crude product (3.0 g) in DMF (15 mL) was slowly added to ethanol (150 mL) resulting 
in the precipitation of a solid material that was isolated by filtration and dried under vacuum. 
The product was purified by Soxhlet extraction with 1,2-dichloroethane followed by THF. 
The succinic acid-capped aniline pentamer (AP) (Scheme S1†) was dried under vacuum for 
48 hours, after which 1.8 g (2.7 mmol, 54% yield) was isolated in an analytically pure form 
in accordance with the literature.1021H NMR (400 MHz, DMSO-d6) δH 9.80 (s, 2H, CONH), 
7.46–7.44 (m, 4H, Ar-H), 7.36 (s, 2H, Ar-H), 7.23 (s, 2H, Ar-H), 7.18 (m, 4H, Ar-H), 7.11 (s, 
2H, Ar-H), 7.04–6.95 (m, 6H, Ar-H), 2.62–2.55 (m, 8H, CH2); 13C NMR (100 MHz, DMSO-
d6) δC 177.24 (COOH), 173.94 (CONH), 140.81 (Ar-C), 138.30 (Ar-C), 137.12 (Ar-C), 
135.65 (Ar-C), 132.32 (Ar-C), 120.44 (Ar-C), 119.47 (Ar-C), 118.36 (Ar-C), 117.50 (Ar-C), 
115.38 (Ar-C), 31.00 (CH2), 29.21 (CH2). ESI-MS (m/z) calculated for C38H35N6O6 [M + H]+ 
requires 672.25; found, 672.25. IR (ATR) νmax cm−1 3293 (NH, amide), 1712 (C O, acid).  
General methodology for the synthesis of the electroactive polyesters. The synthesis of the 
electroactive polyesters adapted from the method of Wei and co-workers.81 In short, alcohol-
terminated poly(ethylene glycol)s or poly(caprolactone)s (3 mmol) were dissolved in N-
methyl-2-pyrrolidone (NMP, 20 mL), to which was added AP (2.0 g, 3.0 mmol), 
dicyclohexylcarbodiimide (DCC, 1.9 g, 9.0 mmol) and 4-dimethylaminopyridine (DMAP, 
0.2 g, 2.0 mmol). The reaction mixture was stirred at room temperature under an inert 
atmosphere of argon. After 72 hours the reaction mixture was filtered and added drop-wise to 
diethyl ether (1.5 L) that was stirred to assure the precipitation of a fine powder of the 
respective polymer. The stir bar was removed and the product was allowed to settle to the 
bottom of the container (typically 15–30 minutes). The diethyl ether was removed via pipette 
suction, and the polymer-rich layer at the bottom of the container was concentrated with a 
rotary evaporator to yield a thick oil. The oil was dissolved/dispersed in chloroform (10 mL), 
after which it was re-precipitated in diethyl ether, and this process of resuspension in 
chloroform followed by re-precipitation in diethyl ether was repeated two more times. The 
resulting polymers were dried under high vacuum for 24 hours. The polymers could be 
reduced to the leucoemeraldine state via brief exposure to aqueous hydrazine for ca. 15 
minutes (after which no further gas was observed to evolve) followed by dialysis against 
ultrapure water in a cellulose dialysis tube with a molecular weight cutoff of ca. 3500 Da, and 
dried under high vacuum for 48 hours.  
Synthesis of electroactive polyester 1. Polyester 1 was synthesized using poly(ethylene 
glycol) with an average molecular weight of 400 Da, and 1.6 g of 1 (Scheme 1) was isolated 
via this procedure, in a yield of 50% by mass. 1H NMR (400 MHz, DMSO-d6): δH = 10.20 (br 
s, CONH), 9.90 (br s, CONH), 7.68 (br, NH), 7.53–7.45 (m, Ar-H), 7.36 (s, Ar-H), 7.24 (d, 
Ar-H), 7.19–6.90 (m, Ar-H), 3.75–3.55 (m, CH2O), 3.52–3.48 (m, CH2O), 2.62–2.55 (m, 
CH2); 13C NMR (100 MHz, DMSO-d6): δC = 174.3 (CO2R), 173.9 (CONH), 173.7 (CONH), 
140.7 (Ar-C), 138.3 (Ar-C), 137.6 (Ar-C), 135.5 (Ar-C), 134.3 (Ar-C), 126.4 (Ar-C), 125.1 
(Ar-C), 120.44 (Ar-C), 119.2 (Ar-C), 118.8 (Ar-C), 117.5 (Ar-C), 115.4 (Ar-C), 72.7 
(CH2O), 70.2 (CH2O), 25.0 (CH2), 24.7 (CH2). IR (ATR) νmax cm−1 3293 (NH, amide), 1732 
(C O, ester).  
Synthesis of electroactive polyester 2. Polyester 2 was synthesized using alcohol-terminated 
poly(ethylene glycol)s with an average molecular weight of 2000 Da, and 4.25 g of 2 
(Scheme 1) was isolated via this procedure, in a yield of 53% by mass. 1H NMR (400 MHz, 
DMSO-d6): δH = 10.20 (br s, CONH), 9.90 (br s, CONH), 7.68 (br, NH), 7.53–7.45 (m, Ar-
H), 7.36 (s, Ar-H), 7.24 (d, Ar-H), 7.19–6.90 (m, Ar-H), 3.75–3.55 (m, CH2O), 3.52–3.48 (m, 
CH2O), 2.62–2.55 (m, CH2); 13C NMR (100 MHz, DMSO-d6): δC solubility too low. IR 
(ATR) νmax cm−1 3293 (NH, amide), 1732 (C O, ester).  
Synthesis of electroactive polyester 3. Polyester 3 was synthesized using poly(caprolactone) 
diol with an average molecular weight of 530 Da, and 2.2 g of 3 (Scheme 2) was isolated via 
this procedure, in a yield of 62% by mass. 1H NMR (400 MHz, DMSO-d6) δH 10.19 (s, 
CONH), 9.89 (s, CONH), 7.68 (br, NH), 7.53–7.45 (m, Ar-H), 7.35 (s, Ar-H), 7.22 (d, Ar-H), 
7.19–6.90 (m, Ar-H), 4.11 (m, CH2O, PCL), 3.75–3.55 (m, CH2O, diethyleneglycol spacer), 
3.52–3.48 (m, CH2O, diethyleneglycol spacer), 2.69–2.55 (m, CH2), 1.66 (m, CH2), 1.55 (m, 
CH2), 1.29 (m, CH2); 13C NMR (100 MHz, DMSO-d6) δC 174.4 (CO2R), 174.2 (CO2R), 173.2 
(CONH), 140.7 (Ar-C), 138.3 (Ar-C), 137.6 (Ar-C), 135.5 (Ar-C), 134.3 (Ar-C), 126.4 (Ar-
C), 125.1 (Ar-C), 120.44 (Ar-C), 119.2 (Ar-C), 118.8 (Ar-C), 117.5 (Ar-C), 115.4 (Ar-C), 
70.2 (CH2O, diethyleneglycol spacer), 68.7 (CH2O, diethyleneglycol spacer), 63.9 (CH2O, 
PCL), 33.8 (CH2), 32.6 (CH2), 32.3 (CH2), 31.4 (CH2), 30.6 (CH2), 29.4 (CH2), 28.2 (CH2), 
25.3 (CH2), 25.0 (CH2), 24.7 (CH2). IR (ATR) νmax cm−1 3293 (NH, amide), 1732 (C O, ester).  
Synthesis of electroactive polyester 4. Polyester 4 was synthesized using poly(caprolactone) 
diol with an average molecular weight of 2000 Da, and 1.0 g of 4 (Scheme 2) was isolated via 
this procedure, in a yield of 25% by mass. 1H NMR (400 MHz, DMSO-d6): δH = 10.19 (s, 
CONH), 9.89 (s, CONH), 7.68 (br, NH), 7.53–7.45 (m, Ar-H), 7.35 (s, Ar-H), 7.22 (d, Ar-H), 
7.19–6.90 (m, Ar-H), 4.11 (m, CH2O, PCL), 3.75–3.55 (m, CH2O, diethyleneglycol spacer), 
3.52–3.48 (m, CH2O, diethyleneglycol spacer), 2.69–2.55 (m, CH2), 1.66 (m, CH2), 1.55 (m, 
CH2), 1.29 (m, CH2); 13C NMR (100 MHz, DMSO-d6): solubility too low. IR (ATR) νmax cm−1 
3293 (NH, amide), 1732 (C O, ester).  
Film preparation and characterization 
Film preparation. Films were prepared by casting solutions of the polymers in 
hexafluoroisopropanol (HFIP, typically 0.1 g mL−1) onto HFIP insoluble substrates, (e.g., 
microscope slides with dimensions of 2.5 cm × 5 cm or glassy carbon electrodes with surface 
areas of 0.0314 cm2). The solvent was allowed to evaporate in a fume hood, and the films 
were subsequently dried under vacuum for 48 hours at room temperature. The polymers were 
doped by the addition of camphorsulfonic acid (CSA) to the HFIP solution prior to casting on 
microscope slides. Unless otherwise stated CSA doping was at a mole ratio of 3 : 1 CSA :
AP.72  
Profilometry. Profilometry was carried out using a Veeco Dektak 6M Stylus Profilometer 
(Veeco Instruments Inc., NY) fitted with a 12.5 μm stylus tip. The profilometer was isolated 
on an air table to reduce ambient vibrations. The profilometer was operated at 10 mg of stylus 
force, and used to record profiles of distances of ca. 1 cm, recording data points every 555 
nm. Data analysis was carried out with the software provided by the manufacturer, which 
allowed the determination of the thickness and roughness of the films. The surface roughness 
parameters are analyzed and reported in accordance with the ISO 25178 series. The average 
roughness (Ra) is the arithmetic average of the deviation from the mean line, and is the most 
used international parameter of roughness, and the root-mean-square roughness (Rq) is based 
upon this. The average height difference between the five highest peaks and the five lowest 
valleys (RzDIN) was determined in accordance with DIN 4768/1 as specified by the 
Deutsches Institut für Normung. Doping the films with CSA altered the surface roughness in 
all cases because protonation of the oligoaniline blocks by the CSA caused rearrangement of 
the polymers on the nanoscale.104  
Conductivity determination. The conductance of films of 1–4 were measured in accordance 
with protocol IPC-TM-650, number 2.5.17.2 described by the Institute for Interconnecting 
and Packaging Electronic Circuits. Films supported on glass slides were examined by 
chronoamperometry using a CHI900C electrochemical workstation (CHI instruments, Austin, 
TX). Chronoamperometric measurements were made with a two-point probe system (copper 
alligator clips), by connecting counter and reference electrodes together. Briefly, two thin 
strips of adhesive-backed copper tape (Ted Pella, Inc., Redding, CA) were attached to the 
films, parallel to one another, separated by a distance of 0.5 cm. The working and counter 
electrodes were clipped on the strips of copper tape, and the current measured for 50 seconds 
during a potential step experiment at 10 V. The electrodes were moved to different positions 
after each measurement, and the current passed was recorded in at least five different 
positions. The resistance (R, Ω) of the films was determined in accordance with eqn (1): 
  
R = V/I (1) 
The resistivity (Ω cm−1) of the films was determined in accordance with eqn (2): 
  
ρ = Rwt/L (2) 
In which: w corresponds to the width of the film in cm (2.5 cm); t corresponds to the 
thickness of the film in cm (as determined via profilometry); and L corresponds to the length 
of the film in cm (0.5 cm). The conductivity (S cm−1) of the films was determined in 
accordance with eqn (3): 
  
σ = 1/ρ (3) 
Differential scanning calorimetry (DSC). DSC experiments were carried out with a DSC 
Q100 (TA Instruments, USA), using airtight aluminum pans. Films were precisely weighed 
into aluminum pans (TA Instruments, USA), and analyses were carried out under a nitrogen 
atmosphere (flow rate of 50 mL min−1). The samples were treated as follows: heated from 
room temperature to 200 °C (10 °C min−1), cooled to 0 °C (10 °C min−1), heated from 0 °C to 
200 °C (5 °C min−1), cooled to 0 °C (5 °C min−1), heated from 0 °C to 200 °C (10 °C min−1), 
and finally cooled to 0 °C (10 °C min−1).  
Thermogravimetric analysis (TGA). TGA was conducted on a TA Instruments TGA Q500 
thermogravimetric analyzer (TA Instruments, USA), using a ramp rate of (10 °C min−1) under 
nitrogen gas. Weight loss from the polymers occurring below 200 °C was ascribed to the 
evaporation of solvents, and above 200 °C it was ascribed to the decomposition of the 
polymers. The polyesters synthesized via the condensation of AP with low molecular weight 
diols, polymers 1 (PEG of ca. 400 Da) and 3 (PCL of ca. 530 Da) respectively, were observed 
to decompose in two steps, first the diol blocks decomposed between 200–300 °C, followed 
by the decomposition of AP above this temperature. By comparison, those polyesters 
synthesized via the condensation of AP with higher molecular weight diols, polymers 2 (PEG 
of ca. 2000 Da) and 4 (PCL of ca. 2000 Da) respectively, displayed somewhat greater thermal 
stabilities, and the diol blocks decomposed between 200–410 °C, followed by the 
decomposition of the aniline pentamer above this temperature.78  
UV-visible absorption spectra of films. UV-visible absorption spectra of very thin films 
supported on quartz microscope slides (with dimensions of 2.5 cm × 1 cm, supplied by Ted 
Pella, Inc.) were recorded at room temperature on a Beckman Coulter DU720 general 
purpose UV-visible spectrophotometer (Beckman Coulter Inc., CA).  
Voltammetry. Voltammetry experiments were carried out using a CHI6273C electrochemical 
analyzer (CH Instruments, Inc.). Polymers (5 mg) were dissolved in DMSO (0.5 mL), doped 
with hydrochloric acid (HCl, 50 μL, 1 M), added to deoxygenated phosphate buffered saline 
(PBS, 50 mL, pH 7.0) that was prepared by bubbling nitrogen through it for 10 minutes. The 
mixture was stirred for 5 minutes under nitrogen prior to filtration to remove the stir bar and 
any insoluble polymer before the electrochemical measurements were made. A three-
electrode system consisting of two Pt meshes as working and counter electrodes, and an 
Ag/AgCl reference electrode. Unless otherwise stated, the scan rate was 20 mV s−1. Solutions 
of the polyesters were metastable, and there was evidence of aggregation of the polymers 
within the duration of the experiment. Those polymers incorporating polyethylene glycol 
chains between the oligoanilines (1 and 2) were somewhat less prone to aggregation than 
those incorporating polycaprolactone chains between the oligoanilines (3 and 4).  
X-ray diffraction (XRD). XRD data was collected on a Rigaku R-Axis Spider diffractometer 
with an image plate detector using a graphite monochromator with CuKα radiation (λ = 
1.5418 Å) at room temperature. The instrument was controlled using Rapid/XRD 
diffractometer control software (Rapid/XRD Version 2.3.8., Rigaku Americas Corporation, 
The Woodlands, TX). The integration of the two dimensional data into a one dimensional 
pattern was accomplished using 2DP (2DP Version 1.0., Rigaku Americas Corporation, The 
Woodlands, TX). Percentage crystallinities were determined by taking the ratio of the 
crystalline area to the amorphous area in the XRD spectrum. Areas were determined by 
profile fitting of the crystalline peaks and amorphous humps. A constant linear background 
was used in the profile fitting to eliminate potential variations in area determination caused 
by subjective selection of shape and level. All XRD pattern analysis was performed using 
JADE software (MDI, v 8.1).  
In vitro drug delivery, degradation and cell culture studies 
Preparation of drug doped films. Films of ca. 3–4 mg were prepared by casting solutions of 
1–4 and DMP (at a mole ratio of 1 : 1 DMP : AP) in hexafluoroisopropanol (typically 0.1 g 
mL−1) onto a glassy carbon electrode (0.0314 cm2, CH Instruments, Inc.) or a glass slide. The 
solvent was allowed to evaporate in a fume hood, and the films were subsequently dried 
under vacuum for 48 hours at 60 °C.  
Drug delivery studies. Voltammetry experiments were carried out using a CHI6273C 
electrochemical analyzer (CH Instruments, Inc.). Phosphate buffered saline (PBS, pH 7.0) 
was deoxygenated for 10 minutes with argon before the electrochemical measurements were 
made.  
Electrochemically-triggered release (i.e., de-doping) of DMP from the films deposited on 
glassy carbon substrates by potential cycling, was achieved using a three-electrode system 
consisting of one polymer film-coated glassy carbon working electrode, a Pt mesh counter 
electrode, and an Ag/AgCl reference electrode in 4 mL PBS. Prior to each experiment there 
was a 10 s “quiet time”, the initial potential was 0 V, the high potential was 0.7 V, the low 
potential was −0.5 V, the initial scan was positive, the current was measured at intervals of 
0.001 V, the scan rate used in all experiments was 50 mV s−1, and this stimulation lasted 62 
seconds. The films were allowed to rest for 14 minutes after which the quantity of DMP in 
solution was quantified by UV spectroscopy. The medium was unchanged between cycles, 
and the data are reported as cumulative release as a percentage of the total mass of drug in the 
film over the period of the experiment. These data are compared to passive DMP release from 
unstimulated films measured every 15 minutes. For experiments using multiple scans, a scan 
from 0.7 V to −0.5 V and back to 0.7 V was regarded as one additional cycle and each cycle 
lasted 48 seconds (see Fig. S7–S10†). 
Electrochemically-triggered release (i.e., de-doping) of DMP from films deposited on glass 
substrates using a potential step was achieved by connecting two thin strips of adhesive-
backed copper tape (Ted Pella, Inc.) were attached to the films, parallel to one another, 
separated by a distance of 1.1 cm. The counter and reference electrodes were connected 
together and clipped to copper tape on one side of the film, and the working electrode was 
clipped to copper tape on the other side of the film. A polycarbonate well with a square hole 
(sides of 0.9 cm) was attached to the film and copper tape using vacuum grease and binder 
clips to assure a firm seal, with PBS (0.5 mL) added to the well. A potential step of +0.6 V 
was applied to each film for 30 seconds, followed by 29.5 minutes of rest after which the 
concentration of DMP in solution was quantified by UV spectroscopy. 
DMP release was quantified by UV spectroscopy using a BioTek Epoch® plate reader 
(BioTek US, Winooski, VT) equipped with a Take3 Micro-volume Plate and Gen5 v2.04 
Software supplied with the plate reader. Two samples of 2 μL were removed from the release 
medium at specific time points and absorbance readings were carried out at 242 nm (the 
characteristic absorbance band of DMP). Absorptions were corrected by subtracting the 
reading of PBS alone from each sample. A standard calibration curve for DMP was plotted to 
define the quantitative relationship between the observed absorbance and the concentration of 
DMP. Prior to the experiment, the mass of the drug-doped polymer film on the substrate was 
determined by subtracting the mass of the substrate from the mass of the polymer-coated 
substrate. Data are plotted as % DMP release relative to the quantity of DMP theoretically in 
the film at the beginning of the experiment, and all data are the average of at least three 
samples. 
Degradation studies. Films (of ca. 4 mg) were incubated in PBS (1 mL) at 25 °C, in the 
absence or presence of cholesterol esterase (4 units per mL, Sigma Aldrich, USA). At 
specific time points the buffer was removed, the films were carefully washed with deionized 
water, and the films were then dried under high vacuum for 22 hours, after which the mass of 
the film was determined on a high precision balance. The buffer (with or without enzymes) 
was replaced, and the mass of the film was recorded over a period of several days. Films 
were undoped to help differentiate degradation from dopant leaching. The mass loss profiles 
are the average of at least three samples.  
Studies of the cytotoxicity of the degradation products of the polymers. The polymers (200 
mg) were sterilized by incubation in 70% ethanol solution, followed by exposure to UV for 
30 minutes and allowed to dry in a sterile tissue culture hood overnight. The polymers were 
subsequently incubated for 5 days at 37 °C in 2 mL of HDF/HMSC growth medium was 
composed of: high glucose Dulbecco's Modified Eagle Medium (DMEM, 440 mL); fetal 
bovine serum (50 mL); antibiotic–antimycotic (5 mL); non-essential amino acids (5 mL), and 
2 ng mL−1 basic fibroblast growth factor. The media was filtered using a sterile Millipore 220 
nm syringe filter and used for subsequent cell culture experiments as follows.  
Commercially available tissue-culture treated Corning® Costar® 96 well tissue culture plates 
were used as substrates upon which HDF cells were seeded at 10 000 cells per cm2 under 100 
μL of medium (one of the following: medium that had previously been incubated with the 
polymers; pristine medium as a positive control experiment; or pristine medium containing 
15 vol% ethanol as a negative control experiment), and incubated at 37 °C, 95% humidity, 
and a CO2 content of 5%. 
After 2 days the cells were washed gently with PBS, followed by the addition of pristine 
medium containing 10% v/v of the AlamarBlue® reagent. After 2.5 hours of culture, the 
medium was aspirated and replaced with medium (either medium that had previously been 
incubated with the polymers, or pristine medium for control experiments). The aspirated 
medium containing the AlamarBlue® reagent was placed in another 96 well plate, and the 
fluorescence was measured with a fluorimeter (Synergy HT Multi-Mode Microplate Reader, 
Biotek US, Winooski, VT). Two controls were considered during the measurement of the 
fluorescence: the first was wells containing medium alone (i.e. no cells or AlamarBlue® 
reagent), which was not fluorescent; and the second was wells that contained the 
AlamarBlue® reagent but no cells (used for baseline correction). Numbers of cell adhered to 
the various surfaces studied herein are reported relative to their initial seeding density of 10
000 cells per cm2, which was assigned an arbitrary value of 100%. After another 2 days (i.e. 
at 4 days after initial seeding) the AlamarBlue® assay was repeated. Results presented are the 
average of eight samples. 
Cell adhesion studies. Commercially available conductive ITO slides were used for control 
experiments. Clean ITO slides and ITO slides coated with polyester films doped with CSA 
(at a mole ratio of 1 : 1 CSA : AP) were inserted in tissue culture plates and sterilized by 
incubation in 70% ethanol solution, followed by exposure to UV for 30 minutes. After 
sterilization, the slides (coated and uncoated) were incubated for 30 minutes under 3 mm of 
medium. HDF/HMSC growth medium was composed of: high glucose Dulbecco's Modified 
Eagle Medium (DMEM, 440 mL); fetal bovine serum (50 mL); antibiotic–antimycotic (5 
mL); non-essential amino acids (5 mL), and 2 ng mL−1 basic fibroblast growth factor. 
Medium was aspirated and replaced prior to HDF or HMSC seeding. Cell viability before 
starting the experiment was determined by the Trypan Blue (Sigma, USA) exclusion method, 
and the measured viability exceeded 95% in all cases. Cells were seeded at 10 000 cells per 
cm2 under 3 mm of medium, and incubated at 37 °C, 95% humidity, and a CO2 content of 
5%. After 2 days the medium was aspirated and the films were washed gently with PBS. 
Cells were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% 
Triton X-100 (Fluka) and 2% bovine serum albumin (BSA) in PBS buffer for 5 min, followed 
by blocking with 2% BSA in PBS buffer for 30 min at room temperature. Actin filaments and 
cell nuclei within cells were stained with Alexa Fluor 488® Phalloidin (Life Technologies, 
USA) for 30 min and 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen, USA) for 5 min. The 
cells were then washed three times with PBS buffer and stored at 4 °C until images were 
acquired. Fluorescence images of cells were captured using a colour CCD camera 
(Optronics® MagnaFire, Goleta, CA, USA) attached to a fluorescence microscope (IX-70; 
Olympus America Inc.). Images are representative of 3 samples.  
Cell proliferation studies. The cell proliferation studies were carried out in accordance with 
previously reported methodology137,138 employing the AlamarBlue® assay. Commercially 
available tissue-culture treated Corning® Costar® tissue culture plates were used for control 
experiments. Polyester films doped with CSA (at a mole ratio of 1 : 1 CSA : AP) were cast in 
tissue culture plates, dried under high vacuum for 48 hours at room temperature and sterilized 
by incubation in 70% ethanol solution, followed by exposure to UV for 30 minutes. After 
sterilization, films were incubated for 30 minutes under 3 mm of medium. HDF/HMSC 
growth medium was composed of: high glucose Dulbecco's Modified Eagle Medium 
(DMEM, 440 mL); fetal bovine serum (50 mL); antibiotic–antimycotic (5 mL); non-essential 
amino acids (5 mL), and 2 ng mL−1 basic fibroblast growth factor. Medium was aspirated and 
replaced prior to HDF seeding. Cell viability before starting the experiment was determined 
by the Trypan Blue (Sigma, USA) exclusion method, and the measured viability exceeded 
95% in all cases. Cells were seeded at 10 000 cells per cm2 under 3 mm of medium, and 
incubated at 37 °C, 95% humidity, and a CO2 content of 5%.  
After 2 days the cells were washed gently with PBS, followed by the addition of fresh 
medium containing 10% v/v of the AlamarBlue® reagent. After 2.5 hours of culture, the 
medium was aspirated and replaced with fresh medium, and 100 μL of the aspirated medium 
containing the AlamarBlue® reagent was placed in a 96 well plate, and the fluorescence was 
measured with a fluorimeter (Synergy HT Multi-Mode Microplate Reader, Biotek US, 
Winooski, VT). Two controls were considered during the measurement of the fluorescence: 
the first was wells containing medium alone (i.e. no cells or AlamarBlue® reagent), which 
was not fluorescent; and the second was wells that contained the AlamarBlue® reagent but 
no cells (used for baseline correction). Numbers of cell adhered to the various surfaces 
studied herein are reported relative to their initial seeding density of 10 000 cells per cm2, 
which was assigned an arbitrary value of 100%. After another 2 days (i.e. at 4 days after 
initial seeding) this process was repeated. The medium was aspirated and replaced once more 
at 6 days after initial seeding, and finally after a total of 8 days in culture the viability of the 
cells was evaluated using a LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells 
(Molecular Probes, Eugene, OR). The medium was removed and cells on the surfaces were 
incubated with 4 μM ethidium and 2 μM calcein AM in PBS for 15 min at 37 °C in the dark. 
Live cells were stained green because of the cytoplasmic esterase activity, which results in 
reduction of calcein AM into fluorescent calcein, and dead cells were stained red by 
ethidium, which enters the cells via damaged cell membranes and becomes integrated into the 
DNA strands. Fluorescence images of cells were captured using a color CCD camera 
(Optronics® MagnaFire, Goleta, CA, USA) attached to a fluorescence microscope (IX-70; 
Olympus America Inc.). Cells were counted with the cell counter tool (plugin) in the open 
source program ImageJ, all cells on all images were counted. Results of AlamarBlue® assays 
presented are the average of four samples and ethidium/calcein stained images are 
representative of 3 samples. 
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